Literature DB >> 17520185

Patterns of care in the radiotherapy of prostate cancer in Northern Bavaria 1998-2000.

Dirk Vordermark1, Dorothee Marold, Susanne Wirth, Ludwig Keilholz, Klaus Pfändner, Thomas Schimpke, Hans-Joachim Thiel, Jochen Willner, Klaus Ziegler, Matthias Guckenberger, Michael Flentje.   

Abstract

PURPOSE: A patterns-of-care study of radiotherapy (RT) in prostate cancer was performed in Northern Bavaria, Germany, to characterize patient selection, treatment strategies and outcome for the time period 1998-2000.
MATERIAL AND METHODS: Patients who received curative-intent radical or postoperative RT were identified from the databases of six centers (one university, five teaching/regional hospitals). Two centers treated < 20 patients and were excluded from further analysis. At the remaining four centers, 148 patients receiving radical RT and 134 undergoing postoperative RT were analyzed for pretreatment and RT characteristics and actuarial biochemical control (BC; ASTRO definition).
RESULTS: All patients were treated with three-dimensional conformal external-beam techniques. In radical RT patients, cT- and cN-stages as well as the frequency of (neo)adjuvant hormonal therapy (53-91%) and RT to pelvic nodes (2-97%) and the mean total RT dose (64.8-71.0 Gy) varied significantly between centers. In postoperative RT, centers differed significantly in R-status, initial prostate-specific antigen (PSA) and nodal RT frequency (2-89%), whereas total RT doses were similar (62.3-64.8 Gy). After radical RT, 5-year BC was 68.6% and differed significantly between centers on univariate analysis. In a multivariate model, only total RT dose showed a trend toward an effect on BC. In postoperative RT patients, overall 5-year BC was 82.1%, and age and initial PSA were associated with BC on multivariate analysis.
CONCLUSION: From 1998 to 2000, radical RT for prostate cancer at the Northern Bavarian centers now studied was performed with three-dimensional conformal technique to conservative total doses and selection criteria for postoperative RT were highly variable.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17520185     DOI: 10.1007/s00066-007-1746-6

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  7 in total

1.  Exposure of treating physician to radiation during prostate brachytherapy using iodine-125 seeds: dose measurements on both hands with thermoluminescence dosimeters.

Authors:  Hans Schiefer; Friedrich von Toggenburg; Wolf Seelentag; Ludwig Plasswilm; Gerhard Ries; Cornelius Lenggenhager; Hans-Peter Schmid; Thomas Leippold; Ladislav Prikler; Bernd Krusche; Jakob Roth; Daniel Engeler
Journal:  Strahlenther Onkol       Date:  2009-10-06       Impact factor: 3.621

2.  Practice patterns in the management of prostate cancer in Spain: results from a national survey among radiation oncologists in 2009.

Authors:  Almudena Zapatero; José López-Torrecilla; Ismael Herruzo; Felipe A Calvo
Journal:  Clin Transl Oncol       Date:  2012-08-02       Impact factor: 3.405

3.  Prostate cancer radiotherapy in Austria: overview on number of patients, intention to treat, and treatment techniques based on data from 2007.

Authors:  Gregor Goldner; Samir Sljivic; Renee Oismueller; Johanna Salinger; Michael Mittermüller; Tanja Langsenlehner; Walter Harder; Gerhard Kametriser; Helmut Eiter; Elisabeth Nechvile
Journal:  Strahlenther Onkol       Date:  2011-04-26       Impact factor: 3.621

4.  Consensus and differences in primary radiotherapy for localized and locally advanced prostate cancer in Switzerland: A survey on patterns of practice.

Authors:  Cédric M Panje; Alan Dal Pra; Thomas Zilli; Daniel R Zwahlen; Alexandros Papachristofilou; Fernanda G Herrera; Oscar Matzinger; Ludwig Plasswilm; Paul Martin Putora
Journal:  Strahlenther Onkol       Date:  2015-05-19       Impact factor: 3.621

5.  Image-guided radiotherapy for prostate cancer. Implementation of ultrasound-based prostate localization for the analysis of inter- and intrafraction organ motion.

Authors:  Michael Pinkawa; Martin Pursch-Lee; Branka Asadpour; Bernd Gagel; Marc D Piroth; Jens Klotz; Sandra Nussen; Michael J Eble
Journal:  Strahlenther Onkol       Date:  2008-12-24       Impact factor: 3.621

Review 6.  Radical external beam radiotherapy for prostate cancer in Japan: differences in the patterns of care among Japan, Germany, and the United States.

Authors:  Kazuhiko Ogawa; Katsumasa Nakamura; Tomonari Sasaki; Hiroshi Onishi; Masahiko Koizumi; Masayuki Araya; Yoshiyuki Shioyama; Atsushi Okamoto; Michihide Mitsumori; Teruki Teshima
Journal:  Radiat Med       Date:  2008-02-27

7.  Neoadjuvant hormonal therapy and external-beam radiotherapy versus external-beam irradiation alone for prostate cancer. A quality-of-life analysis.

Authors:  Michael Pinkawa; Marc D Piroth; Branka Asadpour; Bernd Gagel; Karin Fischedick; Jaroslav Siluschek; Mareike Kehl; Barbara Krenkel; Michael J Eble
Journal:  Strahlenther Onkol       Date:  2009-02-25       Impact factor: 3.621

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.